Investors Writing for Investors
Results 21 - 30 of 1450 : Previous 1 2 3 4 5 6 7 8 9 Next
This High-Yield Portfolio Will Beat the Market
47 weeks in and my dividend picks are already beating the market.
This Just In: Upgrades and Downgrades
Thumbs-up for EXACT Sciences and DepoMed, but Amylin isn't so lucky.
Why 2011's Big Winner Is a Bad Investment
Don't jump into long-term Treasuries.
3 Stock-Moving Binary Events to Watch in 2012
A look at what's coming up in biotech.
How I'll hold myself accountable for all of my screens.
Biotech Post-Holiday Regifting
Sometimes it's better to not have received in the first place.
2 Positive Signs for Ariad Pharmaceuticals
These two simple metrics can save you a lot of pain.
Highest-Yielding Stocks Unlikely to Blow Up
Searching for safe in all the right places.
2011 No Dreamboat for MannKind
An FDA rejection and a long wait is a bad combination.
How These Companies Earned a 22,000% Return
A dollar invested in lobbying can give a company fantastic returns.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK